Literature DB >> 11050591

Erythromelalgia: new theories and new therapies.

J S Cohen1.   

Abstract

Erythromelalgia is a rare condition that has remained an enigma diagnostically and therapeutically for decades. It has been assumed that erythromelalgia, which is characterized by hot, red, intensely painful feet or hands, may be the opposite of Raynaud's phenomenon. However, new research suggests that these two disorders are more similar than dissimilar. Erythromelalgia usually follows a chronic, sometimes progressive and disabling course. New evidence suggests that this may not be a disease entity at all, but a syndrome of dysfunctional vascular dynamics; recent studies demonstrate that this dysfunction is reversible in some patients. This review article presents the latest theories and successful treatments for erythromelalgia, and data from a survey of members of The Erythromelalgia Association, which was formed to provide information about erythromelalgia to doctors and patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050591     DOI: 10.1067/mjd.2000.109301

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

1.  Secondary erythromelalgia successfully treated with patient-controlled epidural analgesia and interferon α-2b: A case report and review of the literature.

Authors:  Xingzhi Li; Yaomin Li; Yao Qu; Laijin Lu
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

2.  Erythromelalgia accompanying rosuvastatin-associated myopathy.

Authors:  Nevio Cimolai; Tomas Cimolai
Journal:  J Dermatol Case Rep       Date:  2009-04-05

Review 3.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

4.  [Erythromelalgia: skin redness and pain].

Authors:  M Dusch; M Schmelz
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

5.  Erythromelalgia.

Authors:  Mark D. P. Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

6.  An Atypical Erythromelalgia on the Chest.

Authors:  Si Hyub Lee; Hee Seong Yoon; Seung Dohn Yeom; Ji Won Byun; Gwang Seong Choi; Jeonghyun Shin
Journal:  Ann Dermatol       Date:  2018-10-26       Impact factor: 1.444

7.  Erythromelalgia.

Authors:  Mark D P Davis; Thom Rooke
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

8.  Sympathetic block for treating primary erythromelalgia.

Authors:  Yoo Jin Bang; Jin Seok Yeo; Si Oh Kim; Young Hoon Park
Journal:  Korean J Pain       Date:  2010-03-10

Review 9.  Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.

Authors:  Joost P H Drenth; Stephen G Waxman
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Experience with oral mexiletine in primary erythromelalgia in children.

Authors:  Javeed Iqbal; Mushtaq I Bhat; Bashir A Charoo; Wajid A Syed; Mushtaq A Sheikh; Imtiyaz N Bhat
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.